News on Hepatitis continually updated from thousands of sources around the net.
17 min ago | Medical News Today
The liver transplant team at Mayo Clinic in Florida has found, based on 12 years of experience, that more than half of patients receiving a new liver can be "fast-tracked" to return to a surgical ward room following their transplant, bypassing a one- or two-day stay in the Intensive Care Unit . In the September issue of the American Journal of Transplantation , the physicians and researchers have turned their knowledge of who can be safely fast-tracked into a scoring system that other transplant centers can also use - thus sparing patients potentially overly aggressive treatment and saving substantial health care dollars.
4 hrs ago | Business Journal
It could cost as much as $480 million to attempt to cure all hepatitis C patients covered by the state's Medicaid program, state health officials testified Monday afternoon before state legislators. "The issue is, do we spend money on this or do we spend the money some other way?" said committee chair Rep. Mitch Greenlick , D-Portland.
5 hrs ago | Renton Reporter
Hepatitis C virus affects large numbers of people in King County, but it often goes unnoticed until it's too late. Now health care providers will be better able to identify and successfully treat people with chronic hepatitis C virus in King County, thanks to a $6 million grant awarded to Public Health - Seattle & King County.
7 hrs ago | LongIsland.com
September 16, 201 4 - Governor Andrew M. Cuomo today signed into law a bill that increases access to hepatitis C, or HCV, tests by allowing physicians and nurse practitioners to authorize registered nurses, when appropriate, to administer the test to a patient without the need for a patient-specific order. This is an expansion of a law signed by Governor Cuomo last year requiring hospitals, clinics and physician offices to offer HCV testing to all persons born between 1945 and 1965 who are receiving in-patient or primary care services.
10 hrs ago | Windsor Beacon
By the time Donnie Missouri met Rosaleita Fulford, the soft-spoken 44-year-old woman had funded a drug habit with prostitution and theft. "I was off the chain," she says.
14 hrs ago | ThinkProgress
The company that makes one of the most expensive pills the world is attempting to expand access to the medication among low-income people who can't afford the $1,000 price tag. Gilead, which manufactures a promising Hepatitis C treatment called Sovaldi, is striking a deal with several generic drugmakers to produce a cheaper version of the drug in 91 countries.
For the 3.2 million people in the United States infected with the hepatitis C virus, disease management can be costly and debilitating. But are the new agents recently approved by the Food and Drug Administration a better way to manage the disease? is a complimentary webinar hosted by Hayes, Inc. that will provide you with the latest information about the new management options being used to fight the disease.
Gregg Alton, executive vice president of Gilead Sciences, discusses distribution of Gilead's hepatitis C pill. looks on during a press conference in New Delhi on September 15, 2014.
The agreement covers generic rights to Gilead's blockbuster drug, Sovaldi, chemically known as sofosbuvir and the experimental combination of sofosbuvir and another Hepatitis C drug, ledipasvir. Under the terms of the deal, Indian companies will benefit from technology transfer to help develop the manufacturing and 'to scale up production as quickly as possible.'
This undated file photo provided by Gilead Sciences shows the hepatitis C medication Sovaldi. Gilead Sciences says it has reached a deal with several generic drugmakers to produce cheaper versions of its popular, expensive hepatitis C drug Sovaldi for use in developing countries.
A single protein may tip the balance between ridding the body of a dangerous virus and enduring life-long chronic infection, according to a report appearing in The Journal of Experimental Medicine . Hepatitis B and C viruses cause chronic infections in roughly three-quarters of infected people, putting these individuals at risk for developing liver diseases including cirrhosis and cancer.
Mylan Inc. said it had licensed a Hepatitis C treatment for developing countries.
Southpointe-based Mylan said Mylan Laboratories Ltd. said its deal with Gilead includes non-exclusive rights for sofosbuvir, also known as Sovaldi, and a single-tablet regimen of ledipasvir/sofosbuvir in 91 countries that have 54 percent of the infected population of Hepatitis C. Mylan said it would be able to manufacture low-cost versions of the medicines, which were approved by the FDA in 2013 and 2014. "Hepatitis C is a growing public health problem in developing countries, with Central and East Asia and North Africa among the regions most affected by this disease.
Of the 264 people with haemophilia who were infected with Hepatitis C through blood or blood products, 106 were also infected with HIV. So far a total of 113 people with haemophilia have died of HIV or Hepatitis C, with 38 dying solely of Hepatitis C. "Too many of our members have died.
The outbreak of West Nile virus in 1999 in the USA, and its continued spread throughout the Americas, parts of Europe, the Middle East and Africa, underscored the need for WNV antiviral development. Here, we review the current status of WNV drug discovery.
DOHA: Foreign workers seeking employment in Qatar will have to screen for hepatitis in their home countries starting from end of this year, according to a senior official. Pre-arrival test for hepatitis will be part of a compulsory medical screening for some chronic diseases.
The next generation version of Gilead Sciences Inc's $84,000 hepatitis C drug, already under fire for its record-breaking costs, is going to be even more expensive. Gregg Alton, Gilead's executive vice president of corporate and medical affairs, declined to give an exact price for the new medicine, the first all-oral treatment for the virus which is expected to launch next month.
Updated: Tue Sep 16, 2014 09:07 pm
Copyright © 2014 Topix LLC